FIELD: medical virology; prophylaxis of epidemic influenza in 3- to 15- years-old children; pediatrics. SUBSTANCE: prophylaxis of influenza in children is achieved by intranasally administering to them live recombinant influenza vaccine prepared from cold-adapted attenuated strains of influenza viruses A and B, or from their recombinants prepared from cold-adapted attenuated strains. EFFECT: effective means for combatting influenza epidemics.
Authors
Dates
1997-12-20—Published
1992-11-16—Filed